Close

Eva Enns

Bio

Education

Affiliations

Preferred Pronouns

Personal Academic Website

Topics of Interest/Expertise
 

Countries of Work/Collaboration

Projects

Papers

Bennis SL, Smith MK, Luo X, Baker JV, Enns EA, Kulasingam S. (2026). Self-reported anal cancer screening experiences in MSM: recency, follow-up, and methodological insights. Frontiers in oncology, (16)

Wu Q, Karim S, Van MT, Enns B, Guerra-Alejos BC, Marshall BDL, Schackman BR, Rio CD, Behrends CN, Enns E, Tookes HE, Rosen-Metsch L, Golden M, Strathdee SA, Mehta SH, Armstrong WS, Nosyk B, Zang X. (2026). Impact of COVID-19 on late HIV diagnosis rates by race/ethnicity in Ending the HIV Epidemic (EHE) priority jurisdictions in the United States. Journal of acquired immune deficiency syndromes (1999)

Hirsch W, Enns EA, Khoruts A, Rajasingham R, Vaughn BP. (2026). Cost-effectiveness of Commercial or Traditional Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Jenness SM, Manuelpillai B, Goodreau SM, Marcus JL, Enns EA, Lucas IL, Martinez CA, Siegler AJ, Sanchez T. (2026). Evolving drivers of preexposure prophylaxis discontinuation among US MSM, 2018-2024. AIDS (London, England)

Anderson EJ, Gandhi NR, Sanchez TH, Enns EA, Jenness SM. (2026). Predictive Models to Identify Factors Associated with a High One-Time Sexual Partnership Rate Among U.S. Men Who Have Sex with Men. AIDS and behavior

Piske M, Guerra-Alejos BC, Van MT, Enns B, Medina MG, Zang X, Armstrong WS, Behrends C, Rio CD, Enns E, Geng EH, Golden MR, Marshall BDL, Mehta SH, Metsch LR, Schackman BR, Strathdee SA, Tookes HE, Nosyk B, . (2026). What Tools Do We Have to End the US HIV Epidemic? A Review of Structural, Biomedical and Implementation Interventions and Their Potential Population Impact. Journal of the International AIDS Society, 29(7)

Duarte HA, Carlucci JG, Schwartz EL, Sam-Agudu NA, Enns EA, Birnbaum JK. (2026). Long-Acting Injectable Cabotegravir/Rilpivirine as a Second-Line ART Regimen for Pregnant and Breastfeeding Women in Kenya: Modeling the Potential Impact on Vertical Transmission. Open forum infectious diseases, 13(8)

Leininger BD, Kuntz KM, Hodges JS, Evans R, Enns E, Johnson PJ, Bronfort G. (2025). Cost-effectiveness of spinal manipulation, exercise, and self-management for spinal pain. Chiropractic & manual therapies, 33(1)

Li Z, Knowlton GS, Wheatley MM, Jenness SM, Enns EA. (2025). Meta-Modeling as a Variance-Reduction Technique for Stochastic Model-Based Cost-Effectiveness Analyses. Medical decision making : an international journal of the Society for Medical Decision Making

Duarte HA, Birnbaum JK, Carlucci JG, Ghazal Y, Ndiema RC, Enns EA. (2025). Modeling the potential impact of viral load monitoring on vertical transmission of HIV in Kenya. AIDS (London, England)

Li Z, Chiddawar TV, Shaw LC, Dennis A, Lieberman A, Kingsepp A, Trinidad AJ, Tuazon E, Welch AE, Chatterjee A, Schackman BR, Enns EA, Walley AY, Green TC, Wagner KD, Winograd RP, Behrends CN, Crable EL, Marshall BDL, Zang X. (2025). A descriptive study of drug overdose epidemics, overdose prevention efforts, and opioid settlement fund distribution across six states. The International journal on drug policy, (147)

Duarte HA, Carlucci JG, Sam-Agudu NA, Abuogi LL, Enns EA, Birnbaum JK. (2025). Modeling the Potential Impact of Mentor Mother Programs on Vertical Transmission of HIV in Kenya. Open forum infectious diseases, 12(10)

Chen K, Enns EA. (2025). Evaluating trade-offs between COVID-19 prevention and learning loss: an agent-based simulation analysis. Royal Society open science, 12(4)

Leininger BD, Johnson PJ, Bronfort G, Kuntz KM, Enns E, Hodges JS, Evans R. (2024). How well do participants in clinical trials represent the U.S. population with chronic neck or back pain?. BMC musculoskeletal disorders, 25(1)

Kinsley AC, Kao SZ, Enns EA, Escobar LE, Qiao H, Snellgrove N, Muellner U, Muellner P, Muthukrishnan R, Craft ME, Larkin DJ, Phelps NBD. (2024). Modeling the risk of aquatic species invasion spread through boater movements and river connections. Conservation biology : the journal of the Society for Conservation Biology

Enns EA, Li Z, McKearnan SB, Kao SZ, Sanstead EC, Simon AB, Mink PJ, Gildemeister S, Kuntz KM. (2024). A Sequential Calibration Approach to Address Challenges of Repeated Calibration of a COVID-19 Model. Medical decision making : an international journal of the Society for Medical Decision Making

Bart G, Korthuis PT, Donohue JM, Hagedorn HJ, Gustafson DH, Bazzi AR, Enns E, McNeely J, Ghitza UE, Magane KM, Baukol P, Vena A, Harris J, Voronca D, Saitz R. (2024). Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use disorder. Addiction science & clinical practice, 19(1)

Bart G, Barth KS, Baukol P, Enns E, Ghitza UE, Harris J, Jelstrom E, Liebschutz JM, Magane KM, Voronca D, Weinstein ZM, Korthuis PT. (2024). Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versus treatment as usual on post-hospital treatment engagement for hospitalized patients with opioid use disorder. Addiction science & clinical practice, 19(1)

Groene EA, Norby FL, Eaton AA, Mason SM, Enns EA, Kulasingam S, Vock DM. (2023). Diagnosed Gonorrhea Among Privately Insured Women: Analysis of United States Claims Data. Journal of women's health (2002)

Wheatley MM, White KM, Peterson AD, Hanft J, Rowles D, Blissett T, Enns EA. (2023). Barriers, opportunities, and potential costs of expanding HIV support services. AIDS care, 35(8)

Groene EA, Boraas CM, Smith MK, Lofgren SM, Rothenberger MK, Enns EA. (2023). Evaluation of Strategies to Improve Uptake of Expedited Partner Therapy for Chlamydia trachomatis Treatment in Minnesota: A Decision Analytic Model. MDM policy & practice, 8(1)

Dorélien AM, Venkateswaran N, Deng J, Searle K, Enns E, Alarcon Espinoza G, Kulasingam S. (2023). Quantifying social contact patterns in Minnesota during stay-at-home social distancing order. BMC infectious diseases, 23(1)

Sanstead EC, Li Z, McKearnan SB, Kao SZ, Mink PJ, Simon AB, Kuntz KM, Gildemeister S, Enns EA. (2023). Adaptive COVID-19 Mitigation Strategies: Tradeoffs between Trigger Thresholds, Response Timing, and Effectiveness. MDM policy & practice, 8(2)

Aby ES, Rajasingham R, Enns EA, Vaughn BP. (2023). Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection. The lancet. Gastroenterology & hepatology, 8(2)

Michalska-Smith M, Enns EA, White LA, Gilbertson MLJ, Craft ME. (2023). The illusion of personal health decisions for infectious disease management: disease spread in social contact networks. Royal Society open science, 10(3)

Alarid-Escudero F, Krijkamp E, Enns EA, Yang A, Hunink MGM, Pechlivanoglou P, Jalal H. (2022). An Introductory Tutorial on Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example. Medical decision making : an international journal of the Society for Medical Decision Making

Wheatley MM, Peterson AD, Wolfson J, Hanft J, Rowles D, Blissett T, Enns EA. (2022). Variation in local Ryan White HIV/AIDS program service use and impacts on viral suppression: informing quality improvement efforts. AIDS care

Jenness SM, Le Guillou A, Lyles C, Bernstein KT, Krupinsky K, Enns EA, Sullivan PS, Delaney KP. (2022). The Role of HIV Partner Services in the Modern Biomedical HIV Prevention Era: A Network Modeling Study. Sexually transmitted diseases

Wheatley MM, Knowlton G, Kao SY, Jenness SM, Enns EA. (2022). Cost-Effectiveness of Interventions to Improve HIV Pre-Exposure Prophylaxis Initiation, Adherence, and Persistence among Men Who Have Sex with Men. Journal of acquired immune deficiency syndromes (1999)

Wheatley MM, Knowlton GS, Butler M, Enns EA. (2022). Cost-Effectiveness of HIV Retention and Re-engagement Interventions in High-Income Countries: A Systematic Literature Review. AIDS and behavior

Chantarat T, Enns EA, Hardeman RR, McGovern PM, Myers SL Jr., Dill J. (2022). Occupational Segregation And Hypertension Inequity: The Implication Of The Inverse Hazard Law Among Healthcare Workers. Journal of economics, race, and policy

Smith MK, Latkin CA, Hutton HE, Chander G, Enns EA, Ha TV, Frangakis C, Sripaipan T, Go VF. (2023). Longitudinal Trajectories of Alcohol Use in Vietnamese Adults with Hazardous Alcohol Use and HIV. AIDS and behavior, 27(6)

Alarid-Escudero F, Krijkamp E, Enns EA, Yang A, Hunink MGM, Pechlivanoglou P, Jalal H. (2022). A Tutorial on Time-Dependent Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example. Medical decision making : an international journal of the Society for Medical Decision Making

Chantarat T, McGovern PM, Enns EA, Hardeman RR. (2022). Predicting the onset of hypertension for workers: does including work characteristics improve risk predictive accuracy?. Journal of human hypertension

Aby ES, Vaughn BP, Enns EA, Rajasingham R. (2022). Cost-effectiveness of fecal microbiota transplantation for first recurrent Clostridioides difficile infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Zhang AZ, Enns EA. (2022). Optimal timing and effectiveness of COVID-19 outbreak responses in China: a modelling study. BMC public health, 22(1)

Groene EA, Boraas C, Smith K, Lofgren S, Rothenberger M, Enns E. (2022). A statewide mixed-methods study of provider knowledge and behavior administering Expedited Partner Therapy for chlamydia and gonorrhea. Sexually transmitted diseases

Popp J, Weinberg DS, Enns E, Nyman JA, Beck JR, Kuntz KM. (2021). Reevaluating the Evidence for Intensive Postoperative Extracolonic Surveillance for Nonmetastatic Colorectal Cancer. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 25(1)

Rao DW, Wheatley MM, Goodreau SM, Enns EA. (2021). Partnership dynamics in mathematical models and implications for representation of sexually transmitted infections: a review. Annals of epidemiology

Malloy GSP, Goldhaber-Fiebert JD, Enns EA, Brandeau ML. (2021). Predicting the Effectiveness of Endemic Infectious Disease Control Interventions: The Impact of Mass Action versus Network Model Structure. Medical decision making : an international journal of the Society for Medical Decision Making

Siriruchatanon M, Liu S, Carlucci JG, Enns EA, Duarte HA. (2021). Addressing Pediatric HIV Pretreatment Drug Resistance and Virologic Failure in Sub-Saharan Africa: A Cost-Effectiveness Analysis of Diagnostic-Based Strategies in Children ≥3 Years Old. Diagnostics (Basel, Switzerland), 11(3)

Cipriano LE, Haddara WMR, Zaric GS, Enns EA. (2021). Impact of university re-opening on total community COVID-19 burden. PloS one, 16(8)

Quan AML, Mah C, Krebs E, Zang X, Chen S, Althoff K, Armstrong W, Behrends CN, Dombrowski JC, Enns E, Feaster DJ, Gebo KA, Goedel WC, Golden M, Marshall BDL, Mehta SH, Pandya A, Schackman BR, Strathdee SA, Sullivan P, Tookes H, Nosyk B, . (2021). Improving health equity and ending the HIV epidemic in the USA: a distributional cost-effectiveness analysis in six cities. The lancet. HIV

Jenness SM, Knowlton G, Smith DK, Marcus JL, Anderson EJ, Siegler AJ, Jones J, Sullivan PS, Enns E. (2021). A decision analytics model to optimize investment in interventions targeting the HIV PrEP cascade of care. AIDS (London, England)

Caro-Vega Y, Alarid-Escudero F, Enns EA, Sosa-Rubí S, Chivardi C, Piñeirúa-Menendez A, García-Morales C, Reyes-Terán G, Sierra-Madero JG, Ávila-Ríos S. (2021). Retention in Care, Mortality, Loss-to-Follow-Up, and Viral Suppression among Antiretroviral Treatment-Naïve and Experienced Persons Participating in a Nationally Representative HIV Pre-Treatment Drug Resistance Survey in Mexico. Pathogens (Basel, Switzerland), 10(12)

Duarte HA, Babigumira JB, Enns EA, Stauffer DC, Shafer RW, Beck IA, Garrison LP Jr., Chung MH, Frenkel LM, Bendavid E. (2020). Cost-effectiveness analysis of pre-ART HIV drug resistance testing in Kenyan women. EClinicalMedicine, (22)

Krijkamp EM, Alarid-Escudero F, Enns EA, Pechlivanoglou P, Hunink MGM, Yang A, Jalal HJ. (2020). A Multidimensional Array Representation of State-Transition Model Dynamics. Medical decision making : an international journal of the Society for Medical Decision Making

Kao SZ, Enns EA. (2020). Follow the Sex: Influence of Network Structure on the Effectiveness and Cost-Effectiveness of Partner Management Strategies for Sexually Transmitted Infection Control. Sexually transmitted diseases, 47(2)

Schwehr NA, Kuntz KM, Enns EA, Shippee ND, Kingwell E, Tremlett H, Carpenter AF, Butler M, . (2020). Informing Medication Discontinuation Decisions among Older Adults with Relapsing-Onset Multiple Sclerosis. Drugs & aging, 37(3)

Rajasingham R, Enns EA, Vaughn BP. (2020). Reply to Author. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Chehrazi N, Cipriano LE, Enns EA. (2019). Dynamics of Drug Resistance: Optimal Control of an Infectious Disease. Operations research, 67(3)

Alarid-Escudero F, Enns EA, Kuntz KM, Michaud TL, Jalal H. (2019). "Time Traveling Is Just Too Dangerous" but Some Methods Are Worth Revisiting: The Advantages of Expected Loss Curves Over Cost-Effectiveness Acceptability Curves and Frontier. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 22(5)

Schwehr NA, Kuntz KM, Butler M, Enns EA, Shippee ND, Kingwell E, Tremlett H, Carpenter AF, . (2020). Age-related decreases in relapses among adults with relapsing-onset multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 26(12)

Alarid-Escudero F, Krijkamp EM, Pechlivanoglou P, Jalal H, Kao SZ, Yang A, Enns EA. (2019). A Need for Change! A Coding Framework for Improving Transparency in Decision Modeling. PharmacoEconomics, 37(11)

Rajasingham R, Enns EA, Khoruts A, Vaughn BP. (2020). Cost-effectiveness of Treatment Regimens for Clostridioides difficile Infection: An Evaluation of the 2018 Infectious Diseases Society of America Guidelines. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 70(5)

Negoescu DM, Enns EA, Swanhorst B, Baumgartner B, Campbell JP, Osterman MT, Papamichael K, Cheifetz AS, Vaughn BP. (2019). Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: A Cost-Effectiveness Analysis in a Simulated Cohort. Inflammatory bowel diseases, 26(1)

Enns EA, Reilly CS, Horvath KJ, Baker-James K, Henry K. (2019). HIV Care Trajectories as a Novel Longitudinal Assessment of Retention in Care. AIDS and behavior, 23(9)

Lee K, Drekonja DM, Enns EA. (2018). Cost-Effectiveness of Antibiotic Prophylaxis Strategies for Transrectal Prostate Biopsy in an Era of Increasing Antimicrobial Resistance. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 21(3)

Krijkamp EM, Alarid-Escudero F, Enns EA, Jalal HJ, Hunink MGM, Pechlivanoglou P. (2018). Microsimulation Modeling for Health Decision Sciences Using R: A Tutorial. Medical decision making : an international journal of the Society for Medical Decision Making, 38(3)

Alarid-Escudero F, MacLehose RF, Peralta Y, Kuntz KM, Enns EA. (2018). Nonidentifiability in Model Calibration and Implications for Medical Decision Making. Medical decision making : an international journal of the Society for Medical Decision Making, 38(7)

Kao SZ, VanderWaal K, Enns EA, Craft ME, Alvarez J, Picasso C, Wells SJ. (2018). Modeling cost-effectiveness of risk-based bovine tuberculosis surveillance in Minnesota. Preventive veterinary medicine, (159)

VanderWaal K, Enns EA, Picasso C, Alvarez J, Perez A, Fernandez F, Gil A, Craft M, Wells S. (2017). Optimal surveillance strategies for bovine tuberculosis in a low-prevalence country. Scientific reports, 7(1)

Thao V, Enns EA, Patrick SW, Levy R, Kozhimannil KB. Decision Science Can Help Policymakers to Identify and Evaluate Policies to Treat Opioid Use Disorder Among Pregnant Women. Women's health issues : official publication of the Jacobs Institute of Women's Health, 28(1)

Enns EA, Kao SY, Kozhimannil KB, Kahn J, Farris J, Kulasingam SL. (2017). Using Multiple Outcomes of Sexual Behavior to Provide Insights Into Chlamydia Transmission and the Effectiveness of Prevention Interventions in Adolescents. Sexually transmitted diseases, 44(10)

Jalal H, Pechlivanoglou P, Krijkamp E, Alarid-Escudero F, Enns E, Hunink MGM. (2017). An Overview of R in Health Decision Sciences. Medical decision making : an international journal of the Society for Medical Decision Making, 37(7)

Enns EA, Reilly CS, Virnig BA, Baker K, Vogenthaler N, Henry K. (2016). Potential Impact of Integrating HIV Surveillance and Clinic Data on Retention-in-Care Estimates and Re-Engagement Efforts. AIDS patient care and STDs, 30(9)

Enns EA, Zaric GS, Strike CJ, Jairam JA, Kolla G, Bayoumi AM. (2016). Potential cost-effectiveness of supervised injection facilities in Toronto and Ottawa, Canada. Addiction (Abingdon, England), 111(3)

Enns EA, Brandeau ML. (2015). Link removal for the control of stochastically evolving epidemics over networks: a comparison of approaches. Journal of theoretical biology, (371)

Enns EA, Cipriano LE, Simons CT, Kong CY. (2015). Identifying best-fitting inputs in health-economic model calibration: a Pareto frontier approach. Medical decision making : an international journal of the Society for Medical Decision Making, 35(2)

Enns EA, Brandeau ML, Igeme TK, Bendavid E. (2011). Assessing effectiveness and cost-effectiveness of concurrency reduction for HIV prevention. International journal of STD & AIDS, 22(10)

Enns EA, Mounzer JJ, Brandeau ML. (2012). Optimal link removal for epidemic mitigation: a two-way partitioning approach. Mathematical biosciences, 235(2)

Enns EA, Brandeau ML. (2011). Inferring model parameters in network-based disease simulation. Health care management science, 14(2)

If you’d like to update your profile, please email modifications to questions@midasnetwork.us.